Skip to main navigation Skip to search Skip to main content

The Dementias Platform UK PET/MR Harmonisation and Test-Retest Study: Assessment of PET Repeatability and Reproducibility Across the National Network

  • Pawel J. Markiewicz
  • , Gerard Thompson
  • , Joanna Wardlaw
  • , Catriona Wimberley
  • , Craig Ritchie
  • , John-Paul Taylor
  • , David Brooks
  • , Ross Maxwell
  • , Michael Firbank
  • , Nigel Hoggard
  • , Li Su
  • , Jim Wild
  • , Philip Hillel
  • , Victoria Rhodes-Bradford
  • , Laura M. Parkes
  • , John T. O’Brien
  • , Stephen F. Carter
  • , Franklin I. Aigbirhio
  • , Tim Fryer
  • , Paul M. Matthews
  • Paresh Malhotra, Gabrielle Grey, Will Hallett, Dilek Ocal, John C. Dickson, Enrico De Vita, David L. Thomas, Nick C. Fox, Giorgios Krokos, Jane E. Mackewn, Paul Marsden, Alexander Hammers, Karl Herholz, Frederik Barkhof, Julian C. Matthews
  • University of Edinburgh
  • University of St Andrews
  • Newcastle University
  • University of Sheffield
  • Sheffield Teaching Hospitals NHS Foundation Trust
  • University of Manchester
  • University of Cambridge
  • Imperial College London
  • University College London
  • UCL Institute of Neurology, University College London
  • University College London Hospital
  • School of Imaging Sciences and Biomedical Engineering
  • NIHR Sheffield Biomedical Research Centre
  • Amsterdam UMC

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)
1 Downloads (Pure)

Abstract

Purpose: Positron emission tomography combined with magnetic resonance
imaging (PET/MR) has not yet achieved the level of adoption of PET/CT. This study aimed to harmonise PET imaging protocols across a national PET/MR network and to quantitatively assess whether PET/MR can achieve reliability comparable to PET/CT. While previous PET test-retest studies have demonstrated good repeatability, they have typically been limited to small cohorts or
restricted site configurations.

Methods: We conducted a multi-site harmonisation and rigorous test-retest study across the network of eight PET/MR scanners. Thirty-seven healthy older participants (65-90 years) underwent harmonised one-hour amyloid PET/MR scans using either [18F]flutemetamol or [18F]florbetaben on two occasions. Retest scans were performed under conditions of same-site repeatability or multi-site reproducibility. Harmonised acquisition and reconstruction protocols were applied, and amyloid burden was quantified on the Centiloid (CL) scale.

Results: CL values across 74 scans showed excellent test-retest agreement (ICC = 0.968), improving to 0.987 after exclusion of one attenuation correction related outlier. Mean test-retest variability was 2.58%. No statistically significant differences were observed across repeatability versus reproducibility conditions, scanner types, or tracers. CL measurements were highly consistent with three
independent blinded visual reads.

Conclusion: This study demonstrates that harmonised PET/MR achieves high reliability comparable to PET/CT. Although the accuracy of attenuation maps requires checks, this study supports the use of PET/MR for quantitative amyloid imaging in research and therapeutic trials, and provide a valuable open resource of image and raw PET/MR data for further methodological development.
Original languageEnglish
Pages (from-to)5110-5129
Number of pages20
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume53
Issue number8
Early online date29 Apr 2026
DOIs
Publication statusPublished - 29 Apr 2026

Cite this